Chemical Works of Gedeon Richter Plc (RGEDF)
OTHER OTC:RGEDF
RGEDF Stock Chart & Stats
$45.28
$2.27(9.11%)
At close: 4:00 PM EDT
$45.28
$2.27(9.11%)
Day’s Range― - ―
52-Week Range$27.00 - $45.28
Previous CloseN/A
Volume3.00
Average Volume (3M)28.00
Market Cap
$6.97B
Enterprise Value$1.71T
Total Cash (Recent Filing)$136.62B
Total Debt (Recent Filing)$21.74B
Price to Earnings (P/E)9.3
Beta0.63
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.13%
Share Statistics
EPS (TTM)1306.92
Shares Outstanding186,374,860
10 Day Avg. Volume0
30 Day Avg. Volume28
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap244.76
Enterprise Value/Revenue1.99
Enterprise Value/Gross Profit2.92
Enterprise Value/Ebitda4.50
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Chemical Works of Gedeon Richter News
RGEDF FAQ
What was Chemical Works of Gedeon Richter Plc’s price range in the past 12 months?
Chemical Works of Gedeon Richter Plc lowest stock price was $27.00 and its highest was $45.28 in the past 12 months.
What is Chemical Works of Gedeon Richter Plc’s market cap?
Chemical Works of Gedeon Richter Plc’s market cap is $6.97B.
When is Chemical Works of Gedeon Richter Plc’s upcoming earnings report date?
Chemical Works of Gedeon Richter Plc’s upcoming earnings report date is Aug 07, 2026 which is in 55 days.
How were Chemical Works of Gedeon Richter Plc’s earnings last quarter?
Chemical Works of Gedeon Richter Plc released its earnings results on May 12, 2026. The company reported $1.153 earnings per share for the quarter, beating the consensus estimate of N/A by $1.153.
Is Chemical Works of Gedeon Richter Plc overvalued?
According to Wall Street analysts Chemical Works of Gedeon Richter Plc’s price is currently Overvalued.
Does Chemical Works of Gedeon Richter Plc pay dividends?
Chemical Works of Gedeon Richter Plc pays a Annually dividend of $2.153 which represents an annual dividend yield of 5.13%. See more information on Chemical Works of Gedeon Richter Plc dividends here
What is Chemical Works of Gedeon Richter Plc’s EPS estimate?
Chemical Works of Gedeon Richter Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chemical Works of Gedeon Richter Plc have?
Chemical Works of Gedeon Richter Plc has 186,374,860 shares outstanding.
What happened to Chemical Works of Gedeon Richter Plc’s price movement after its last earnings report?
Chemical Works of Gedeon Richter Plc reported an EPS of $1.153 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.85%.
Which hedge fund is a major shareholder of Chemical Works of Gedeon Richter Plc?
Currently, no hedge funds are holding shares in RGEDF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Chemical Works of Gedeon Richter Plc
Gedeon Richter Plc specializes in the creation and manufacturing of medicinal products. Its business activities are organized into three primary divisions: Pharmaceuticals, Wholesale & Retail, and Other operations. The Pharmaceutical division encompasses the complete lifecycle of drug products, from initial research and development through to production, promotion, and ultimate distribution. The Wholesale & Retail segment leverages a comprehensive network of distribution firms and pharmacies across diverse regional markets to ensure these products reach consumers. Lastly, the "Others" segment comprises various entities within the group that furnish essential marketing and sales assistance. This enterprise was founded in 1901 by Gedeon Richter, and its corporate headquarters are located in Budapest, Hungary.
RGEDF Company Deck
RGEDF Earnings Call
Q4 2026
0:00 / 0:00
Technical Analysis
Dr Reddy's Laboratories
―
Teva Pharmaceutical
―
Perrigo Company
―
AstraZeneca
―
Pfizer
―
GlaxoSmithKline
―
Ownership Overview
―
Insiders
15.25% Mutual Funds
0.23% Other Institutional Investors
78.87% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---